drugset / Trial / NCT01203202
Phase 2 Trial of PED-1 and PED-2 in Male Patients With Premature Ejaculation
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate whether PED-1 (15mg) and PED-2 (30mg) are tolerable and effective in the treatment of premature ejaculation.
Timeline
- Start
- 2010-09
- Primary completion
- 2011-01
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clomipramine | Small molecule | 15 mg | — |
| Subject | Clomipramine | Small molecule | 30 mg | — |